Recalling firm
ASTRAZENECA PHARMACEUTICALS
Product type
Drug
Status
Ongoing
Report date
2025-10-22
Distribution
Nationwide in the U.S
Firm state
MD
Product quantity
916 pre-filled syringes
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental MonitoringReason for recall
Lack of Assurance of Sterility:
Product description
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30
Code / lot info
Lot YJ0152, Expiry: 01/31/2028.
Other recalls SPEQ maps to Environmental Monitoring
See all Environmental Monitoring recalls →Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.